Figure 3

Relapse-free (RFS) (A) and metastasis-free survival (MFS) (B) curves according to F. nucleatum status in the merged cohort (Nā=ā142 evaluable patients).

Relapse-free (RFS) (A) and metastasis-free survival (MFS) (B) curves according to F. nucleatum status in the merged cohort (Nā=ā142 evaluable patients).